Compare Teradyne, Inc. (TER) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Teradyne, Inc. vs UnitedHealth Group Inc — how do they compare? Teradyne, Inc. trades at $402.68 (market cap $62.34B), while UnitedHealth Group Inc trades at $379.3 (market cap $332.96B). The key difference: UnitedHealth Group Inc is far larger — about 5.3× Teradyne, Inc.'s market cap, and UnitedHealth Group Inc pays the higher dividend (2.5%). Which is the better fit depends on your goals — on Pluang, investors hold Teradyne, Inc. for 37 Days and UnitedHealth Group Inc for 97 Days on average.
| TER | UNH | |
|---|---|---|
Market Cap | $62.34B | $332.96B |
Volume | 3,368,404 | 7,273,749 |
Sector | Technology | Health |
52-Week High | $483.84 | $436.35 |
52-Week Low | $132.05 | $259.02 |
Typical Hold Time | 37 Days | 97 Days |
Enterprise Value | $62.08B | $374.82B |
Dividend Yield | 0.13% | 2.5% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Teradyne (TER) trades at $398.72, down 3.17% on the day, but maintains a bullish technical outlook with strong support at $388 and resistance at $410. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $2.47 exceeding the $2.09 estimate. Revenue for 2025 reached $3.19 billion, and net income margin stands at 25.77%. Recent developments include the launch of the Magnum E2 memory test system and Iris 100 for microLED devices, targeting AI and high-performance computing demand.
The outlook for TER is positive, driven by AI-driven test equipment demand and consistent earnings outperformance. Risks include reliance on semiconductor cycles and competitive pressure from peers like KLAC. Analysts are bullish with a consensus price target of $461.50, representing a 15.7% upside from the current price. Institutional buying and a lack of sell ratings underscore confidence in growth prospects.
UnitedHealth Group (UNH) trades at $370.95, down 1.34% on the day, amid a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $6.38 versus $4.91 expected, and raised full-year guidance. Revenue for 2025 reached $447.57 billion, though net income margin declined to 2.69%. Analyst consensus remains strongly bullish with an 82.69% buy rating and a $470.11 price target, suggesting significant upside from current levels.
UNH presents a compelling investment case driven by earnings beats, raised 2026 outlook, and strategic initiatives like AI investment in Optum. Key risks include regulatory pressures in healthcare, volatility from Medicare Advantage plan changes, and margin compression. The stock's valuation at a P/E of 23.84 appears reasonable given growth prospects, but investors should weigh execution risks against the positive analyst sentiment and institutional backing.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Teradyne, Inc.
Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing, which made up 71% of 2021 sales. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.
Read more on TER →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
